TENAX THERAPEUTICS, INC.
Data quality: 100%
TENX
Nasdaq
Manufacturing
Chemicals
$15.16
▲
$0.11
(0.73%)
Mkt Cap: 260.72 M
Price
$15.16
Mkt Cap
260.72 M
Day Range
$14.79 — $15.34
52-Week Range
$4.63 — $18.38
Volume
677,452
Open $15.00
50D / 200D Avg
$13.37
13.39% above
50D / 200D Avg
$9.33
62.57% above
Quick Summary
Key Takeaways
Negative free cash flow of -35.80 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-52.72%
Below sector avg (-51.02%)
ROIC-44.65%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio15.58
Interest CoverageN/A
Valuation
PE (TTM)
-4.96
Below sector avg (-1.98)
P/B Ratio2.71
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (44 peers)
Peer Comparison
vs Manufacturing sector median (44 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -5.0 | -2.0 |
| P/B | 2.7 | 5.1 |
| ROE % | -52.7 | -51.0 |
| Net Margin % | — | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -52.60 M |
| ROE | -52.72% | ROA | -50.41% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -35.80 M |
| ROIC | -44.65% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 15.58 |
| Interest Coverage | N/A | Asset Turnover | 0.00 |
| Working Capital | 96.21 M | Tangible Book Value | 96.21 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4.96 | Forward P/E | N/A |
| P/B Ratio | 2.71 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -13.73% | ||
| Market Cap | 260.72 M | Enterprise Value | 161.32 M |
| Per Share | |||
| EPS (Diluted TTM) | -1.34 | Revenue / Share | 0.00 |
| FCF / Share | -2.08 | OCF / Share | -2.08 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 68.06% |
| SBC-Adj. FCF | -50.17 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | — | — | — |
| Net Income | -52.60 M | -17.60 M | 7.71 M | -11.05 M | -32.47 M |
| EPS (Diluted) | -1.34 | -1.15 | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -56.39 M | -19.49 M | 8.23 M | -11.05 M | 32.73 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 32.67 M | 12.71 M | 3.23 M | 5.38 M | 25.15 M |
| SG&A Expenses | — | — | — | — | 7.58 M |
| D&A | — | 0.0 | 7,570.0 | 5,143.0 | 4,116.0 |
| Interest Expense | 0.0 | 23,000.0 | 23,967.0 | 4,443.0 | 949.0 |
| Income Tax | 0.0 | 0.0 | — | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 104.23 M | 96.69 M | 11.68 M | 3.40 M | 5.99 M |
| Total Liabilities | 7.16 M | 4.69 M | 3.59 M | 1.91 M | 1.75 M |
| Shareholders' Equity | 97.07 M | 91.99 M | 8.10 M | 1.49 M | 4.24 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 97.60 M | 94.90 M | — | 2.12 M | 5.58 M |
| Current Assets | 104.23 M | 96.69 M | 11.68 M | 3.21 M | 5.69 M |
| Current Liabilities | 7.16 M | 4.69 M | 3.59 M | 1.85 M | 1.56 M |
{"event":"ticker_viewed","properties":{"ticker":"TENX","listing_kind":"stock","pathname":"/stocks/tenx","exchange":"Nasdaq","country":"US"}}